IT8448983A0 - Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina - Google Patents
Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridinaInfo
- Publication number
- IT8448983A0 IT8448983A0 IT8448983A IT4898384A IT8448983A0 IT 8448983 A0 IT8448983 A0 IT 8448983A0 IT 8448983 A IT8448983 A IT 8448983A IT 4898384 A IT4898384 A IT 4898384A IT 8448983 A0 IT8448983 A0 IT 8448983A0
- Authority
- IT
- Italy
- Prior art keywords
- uridine
- treatment
- pharmaceutical agent
- active pharmaceutical
- brain diseases
- Prior art date
Links
- 208000014644 Brain disease Diseases 0.000 title 1
- 239000008186 active pharmaceutical agent Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT48983/84A IT1178044B (it) | 1984-10-09 | 1984-10-09 | Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina |
| EP85830247A EP0178267A3 (en) | 1984-10-09 | 1985-10-02 | a uridine-based pharmaceutically active agent for the treatment of cerebral pathologies |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT48983/84A IT1178044B (it) | 1984-10-09 | 1984-10-09 | Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| IT8448983A0 true IT8448983A0 (it) | 1984-10-09 |
| IT8448983A1 IT8448983A1 (it) | 1986-04-09 |
| IT1178044B IT1178044B (it) | 1987-09-03 |
Family
ID=11269269
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT48983/84A IT1178044B (it) | 1984-10-09 | 1984-10-09 | Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP0178267A3 (it) |
| IT (1) | IT1178044B (it) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1321994C (en) * | 1987-10-28 | 1993-09-07 | Reid Von Borstel | Acylated uridine and cytidine and uses thereof |
| US5268365A (en) * | 1988-03-11 | 1993-12-07 | Rudolph Frederick B | Nucleotides, nucleosides, and nucleobases in immune function restoration enhancement or maintenance |
| IT1219667B (it) * | 1988-06-21 | 1990-05-24 | Polifarma Spa | Impiego di uridina nel trattamento farmacologico di disturbi dovuti ad alterato equilibrio dopaminergico |
| US20030026782A1 (en) | 1995-02-07 | 2003-02-06 | Arthur M. Krieg | Immunomodulatory oligonucleotides |
| US5962459A (en) * | 1996-05-28 | 1999-10-05 | Polifarma S.P.A. | Therapeutic active agent for treatment of neuron degenerative diseases |
| IT1290781B1 (it) * | 1996-05-28 | 1998-12-10 | Polifarma Spa | Agente attivo terapeutico per il trattamento di malattie degenerative neuronali. |
| US8143234B2 (en) * | 1998-07-31 | 2012-03-27 | Massachusetts Institute Of Technology | Uridine administration improves phosphatide synthesis, synaptic transmission and cognitive function |
| DK1870103T3 (da) * | 1998-07-31 | 2010-01-11 | Massachusetts Inst Technology | Anvendelse af uridin i kombination med cholin i behandling af hukommelsesforsstyrrelse |
| US8314064B2 (en) * | 1998-07-31 | 2012-11-20 | Massachusetts Institute Of Technology | Uridine administration stimulates membrane production |
| US8518882B2 (en) * | 1998-07-31 | 2013-08-27 | Massachusetts Institute Of Technology | Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same |
| US20050203053A1 (en) * | 1999-07-30 | 2005-09-15 | Wurtman Richard J. | Uridine administration improves phosphatide synthesis, synaptic transmission and cogntive function |
| US8551452B2 (en) | 2007-11-02 | 2013-10-08 | Massachusetts Institute Of Technology | Uridine dietary supplementation compliance methods and use thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR4260M (it) * | 1964-11-18 | 1966-07-04 |
-
1984
- 1984-10-09 IT IT48983/84A patent/IT1178044B/it active
-
1985
- 1985-10-02 EP EP85830247A patent/EP0178267A3/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| IT1178044B (it) | 1987-09-03 |
| IT8448983A1 (it) | 1986-04-09 |
| EP0178267A3 (en) | 1988-09-21 |
| EP0178267A2 (en) | 1986-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1177553B (it) | Composti farmacologicamente attivi per il trattamento di affezioni gastrointestinali e procedimento di preparazione | |
| NO864126D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridon-derivater. | |
| NO864879L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tiazolforbindelser. | |
| NO864674D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive cefemforbindelser. | |
| NO169438C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser | |
| NO862373D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tienopyridoner. | |
| IT8448983A0 (it) | Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina | |
| NO883485D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser. | |
| NO165071C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre. | |
| IT1230115B (it) | Procedimento per combattere le malattie fungine delle piante | |
| NO880667D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser. | |
| NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO884176L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive amidinoderivater. | |
| IT8721115A0 (it) | Fitopreparato per la cura di affezioni cutanee. | |
| NO164899C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser. | |
| NO864101D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
| NO168247C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-metoksy-alkyl-ammonium-tetrahydrofuraner. | |
| IT1216820B (it) | Procedimento per combattere le malattie fungine delle piante | |
| NO882281D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. | |
| NO164973C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive gem-dihalo- og tetrahalo-1,2-diamino-4,9,-diaza-dodecaner. | |
| NO168357C (no) | Analogifremgangsmaate for fremstilling av terapeutiske aktive disulfider | |
| IT1224741B (it) | Dispositivo per il trattamento delle malattie delle gengive | |
| FR2604707B1 (fr) | Procede de preparation d'un compose therapeutique actif | |
| NO883959L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive fenolestere. | |
| NO882282L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider. |